Citycon Oyj: Flagging notification in accordance with Chapter 9 Section 10 of the Finnish Securities Markets Act Read more about Citycon Oyj: Flagging notification in accordance with Chapter 9 Section 10 of the Finnish Securities Markets Act
Description of the 2023-2024 treasury share buy-back programme submitted by the Board of Directors for the approval of the Combined General Meeting of Shareholders of 13 April 2023 Read more about Description of the 2023-2024 treasury share buy-back programme submitted by the Board of Directors for the approval of the Combined General Meeting of Shareholders of 13 April 2023
DNB BANK ASA - status of share buy-back programme after week 8 2023 Read more about DNB BANK ASA - status of share buy-back programme after week 8 2023
ALTUVIIIO™ approved by the U.S. FDA: this positive event triggers impairment reversal, positively impacting 2022 IFRS net income; no change on business net income (non-IFRS) Read more about ALTUVIIIO™ approved by the U.S. FDA: this positive event triggers impairment reversal, positively impacting 2022 IFRS net income; no change on business net income (non-IFRS)